We are testing a new medication for patients with advanced solid tumors who have not yet received immune checkpoint inhibitors. The goal is to evaluate its safety and how well it may control the disease.
Health conditions and diseases that the clinical trial is designed to study and treat.
Advanced Non-Small Cell Lung Cancer (NSCLC) refers to lung cancer that has progressed to later stages (III or IV), where it may have spread to other parts of the body. This type of cancer is often treated with various therapies, including immunotherapy.
Advanced Melanoma is a serious form of skin cancer that has spread beyond the skin to other parts of the body. It can be aggressive and may require advanced treatment options, including immunotherapy.
Urothelial Carcinoma is a type of cancer that occurs in the bladder and can be aggressive, especially in its advanced stages. It may require various treatment approaches, including immunotherapy.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.
